Scholarly Works

FDA ovarian cancer clinical trial endpoints...

Journal article

FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper

Authors

Herzog TJ; Ison G; Alvarez RD; Balasubramaniam S; Armstrong DK; Beaver JA; Ellis A; Tang S; Ford P; McKee A

Journal

Gynecologic Oncology, Vol. 147, No. 1, pp. 3–10

Publisher

Elsevier

Publication Date

October 1, 2017

DOI

10.1016/j.ygyno.2017.08.012

ISSN

0090-8258

Associated Experts

Shangguo Tang

Associate Professor (Part-Time), Faculty of Health Sciences

Labels

Fields of Research (FoR)

3215 Reproductive medicine 32 Biomedical and Clinical Sciences 3202 Clinical sciences 3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

Carcinoma, Ovarian Epithelial Clinical Trials as Topic Endpoint Determination Female Humans Neoplasms, Glandular and Epithelial Ovarian Neoplasms Patient Reported Outcome Measures United States United States Food and Drug Administration

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback